MedPath

a clinical trial study the effect of exercise with drug management to drug management in quality of life in patient with interstitial lung disease

Not Applicable
Suspended
Conditions
Health Condition 1: J849- Interstitial pulmonary disease, unspecified
Registration Number
CTRI/2021/02/030920
Lead Sponsor
Jawaharlal Institute of Post Graduate Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

all ILD type patient on stable medical therapy

Exclusion Criteria

Not provided

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pulmonary Rehabilitation may help in improving the exercise capacity and health related quality of life in patients with ILDTimepoint: effects of pulmonary rehabilitation assessed in 2 month and 6 month of pulmonary rehabilitation
Secondary Outcome Measures
NameTimeMethod
physiotherapy with standard pharmacotherapy on quality of life of patients with interstitial lung disease afterr 2 months of nterventionTimepoint: 2 months of physiotherapy <br/ ><br>followup for 6 months
© Copyright 2025. All Rights Reserved by MedPath